Clozapine-induced tardive dyskinesia and hypothyroidism

Journal of Neuropsychiatry (Impact Factor: 2.77). 02/2006; 18(2):245-6. DOI: 10.1176/appi.neuropsych.18.2.245
Source: PubMed


Available from: Harpreet Duggal, May 16, 2015
1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: A novel fumed silica-supported nitrogenous platinum complex was conveniently prepared from cheap γ-aminopropyltriethoxysilane via immobilization on fumed silica in toluene, followed by a reaction with hexachloroplatinic acid. The title complex was characterized by fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and X-ray photoelectron spectroscopy (XPS). It was found that the complex is an efficient and stable catalyst for the hydrosilylation of olefins with triethoxysilane. The title platinum complex could be separated by simple filtration and reused several times without any appreciable loss in the catalytic activity.
    ChemInform 09/2011; 696(9):1845-1849. DOI:10.1016/j.jorganchem.2011.02.021
  • [Show abstract] [Hide abstract]
    ABSTRACT: Clozapine has been used in the treatment of schizophrenia for about two decades and extensive data have been accumulated with regard to its use in various parts of the world. However, in contrast to Western countries, there are few studies which have evaluated the usefulness of clozapine in Indian patients. This article attempts to review the available data on clozapine originating from India. This review reflects the fact that there are few studies from the Indian subcontinent and most of these are case reports. In view of the same, there is a need for further research to evaluate the effectiveness of clozapine in India.
    Indian Journal of Psychiatry 04/2010; 52(2):168-73. DOI:10.4103/0019-5545.64592
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To describe a case of myxedema coma (MC) associated with combination aripiprazole and sertraline therapy. A 41-year-old male presented to the emergency department with confusion, right-sided numbness and tingling, slurred speech, dizziness, and facial edema. His blood pressure was 160/113 mm Hg, with a pulse of 56 beats/min and temperature of 35.4 degrees C. Initial abnormal laboratory values included creatine kinase (CK) 439 U/L; serum creatinine 1.6 mg/dL; aspartate aminotransferase 85 U/L; and alanine aminotransferase 35 U/L. Repeat cardiac markers revealed an elevated CK level of 3573 U/L with a CK-MB of 24 ng/mL. Thyroid function tests showed thyroid-stimulating hormone 126.4 microIU/mL and free thyroxine 0.29 ng/dL. Home medications of unknown duration were sertraline 200 mg and aripiprazole 20 mg daily. He was admitted to the intensive care unit and initially treated with intravenous levothyroxine and dexamethasone. By hospital day 4, the patient was clinically stable and discharged to home. Myxedema coma, the most significant form of hypothyroidism (HT), is a rare but potentially fatal condition. The known precipitating causes of MC were ruled out in this patient, which left his home medications as the likely cause. Cases of HT caused by certain atypical antipsychotics and antidepressants are found in the literature, but none was reported with aripiprazole therapy. There are also no reported cases of sertraline or aripiprazole inducing MC. Use of the Naranjo probability scale indicates that the combination of aripiprazole and sertraline was a probable inducer of MC in this patient. Due to the widespread use of psychotropic medications, clinicians should be reminded of the rare, yet life-threatening, occurrence of MC when treating patients, especially with combination therapies such as sertraline and aripiprazole.
    Annals of Pharmacotherapy 12/2009; 43(12):2113-6. DOI:10.1345/aph.1M369 · 2.92 Impact Factor